T
Turnstone Biologics Corp
NASDAQ:TSBX
Turnstone Biologics Corp
NASDAQ:TSBX
Price:
0.355
USD
Market Cap:
$8.2m
Income Statement
Earnings Waterfall
Turnstone Biologics Corp
Turnstone Biologics Corp
Income Statement
Turnstone Biologics Corp
Turnstone Biologics Corp
Currency: USD
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue |
93
N/A
|
93
N/A
|
19
-79%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||
| Operating Expenses |
(146)
|
(165)
|
(78)
|
(79)
|
(80)
|
(79)
|
(72)
|
(59)
|
|
| Selling, General & Administrative |
(27)
|
(32)
|
(18)
|
(19)
|
(18)
|
(18)
|
(16)
|
(16)
|
|
| Research & Development |
(120)
|
(134)
|
(60)
|
(61)
|
(61)
|
(61)
|
(56)
|
(43)
|
|
| Operating Income |
(54)
N/A
|
(73)
-35%
|
(59)
+19%
|
(79)
-34%
|
(80)
0%
|
(79)
+1%
|
(72)
+8%
|
(59)
+18%
|
|
| Pre-Tax Income | |||||||||
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
|
| Total Other Income |
2
|
3
|
4
|
4
|
5
|
4
|
2
|
(2)
|
|
| Pre-Tax Income |
(52)
N/A
|
(70)
-33%
|
(55)
+20%
|
(75)
-35%
|
(75)
+0%
|
(75)
-1%
|
(71)
+6%
|
(63)
+11%
|
|
| Net Income | |||||||||
| Tax Provision |
(0)
|
(0)
|
0
|
0
|
0
|
1
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(52)
|
(70)
|
(55)
|
(75)
|
(75)
|
(74)
|
(71)
|
(63)
|
|
| Net Income (Common) |
(52)
N/A
|
(70)
-33%
|
(55)
+21%
|
(75)
-36%
|
(75)
+0%
|
(74)
+0%
|
(71)
+5%
|
(63)
+11%
|
|
| EPS (Diluted) |
-2.37
N/A
|
-4.01
-69%
|
-4.78
-19%
|
-3.25
+32%
|
-3.24
+0%
|
-3.23
+0%
|
-3.07
+5%
|
-2.73
+11%
|
|
Switch to:
Switch to:
See Also
Discover More
